CoreRx is a contract development and manufacturing organization that provides formulation development, testing and pharmaceutical packaging services. Read more

285 Followers on Owler
285 Followers on Owler
285 Followers on Owler
285 Followers on Owler

CoreRx is a contract development and manufacturing organization that provides formulation development, testing and pharmaceutical packaging services. Read more

Todd R Daviau's photo - President & CEO of CoreRx

President & CEO

Todd R Daviau

CEO Approval Rating

85/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Formex is CoreRx's top competitor. Formex is a Private company that was founded in San Diego, California in 2013. Formex operates in the Health Care Supplies industry. Formex has 169 fewer employees vs. CoreRx.

Tergus Pharma has been one of CoreRx's top competitors. Tergus Pharma is headquartered in Durham, North Carolina, and was founded in 2012. Tergus Pharma is in the Health Care Services industry. Tergus Pharma generates 26% the revenue of CoreRx.

KBI Biopharma is perceived as one of CoreRx's biggest rivals. KBI Biopharma was founded in 1996 in Durham, North Carolina. KBI Biopharma competes in the Biotechnology field. KBI Biopharma generates $30.8M more revenue than CoreRx.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $31.5M a good estimate for CoreRx's revenue?

Acquisitions

No recent acquisitions found related to CoreRx

CoreRx Funding History

$7M$12M$15M

Since CoreRx was founded in 2006, it has participated in 3 rounds of funding. In total CoreRx has raised $15.0M. CoreRx's last funding round was on Mar 2019 for a total of $3.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2019
$3M
-
Equity
Mar 2017
$5M
-
Equity
Mar 2015
$7M

Since CoreRx was founded in 2006, it has participated in 3 rounds of funding. In total CoreRx has raised $15.0M. CoreRx's last funding round was on Mar 2019 for a total of $3.0M

Investments

No recent investments found related to CoreRx

CoreRx News

January 20, 2021PE Hub Network

NovaQuest buys CoreRx, global contract development and manufacturing organization

Affiliates of Signet Healthcare Partners, an existing CoreRx investor in CoreRx since 2015, will reta... See more »
January 19, 2021BioSpace

Signet Healthcare and Bionpharma Sell CoreRx, a Leading Contract Development and Manufacturer

Signet Healthcare Partners and Bionpharma Inc today announced the sale of CoreRx, a global contract d... See more »
January 19, 2021WRAL TechWire

Cashing in on soaring market, NovaQuest acquires life science firm; Goldman Sachs helps

With the global pandemic driving 7% annual growth in life science service companies, Raleigh-based No... See more »
August 10, 2020Contract Pharma

CoreRx Fully Operational in New Product Development Center

Expansion gives CoreRx's clients access to over 150,000 sq. ft. of space at the ICOT center campus.... See more »
February 10, 2020Contract Pharma

JanOne Strikes Clinical Deal with CoreRx

Lead drug clinical candidate be manufactured by CoreRX Pharma with phase 2b trials expected to begin ... See more »
April 24, 2019The Business Journals

Meet Robert Berg, a 2019 CFO of the Year honoree

Robert Berg Chief financial officer CoreRx Pharma What inspired you to become a finance executive? I ... See more »
October 30, 2018PharmiWeb

CoreRx Completes Installation Of The Optel Line Master Serialization And Aggregation System For Support Of Commercial Liquid Dosage Form Manufacturing

CoreRx Completes Installation Of The Optel Line Master Serialization And Aggregation System For Suppo... See more »

CoreRx Blogs

September 12, 2019CoreRx Blog

Biotech Stock On The Radar: Aimmune Awaits Adcom Test

The post Biotech Stock On The Radar: Aimmune Awaits Adcom Test appeared first on CoreRx®.... See more »
June 2, 2019CoreRx Blog

CoreRx, Inc. announces that its client Bionpharma Inc. has received FDA approval for a generic version of Banzel® (Rufinamide) Oral Suspension

Clearwater, Florida- June 3, 2019 - CoreRx, Inc. announces that its client Bionpharma Inc. has receiv... See more »
May 13, 2019CoreRx Blog

CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics' Investigational Peanut Allergy Treatment

Clearwater, Florida, May 14, 2019 - CoreRx, Inc. today announced that it has executed a commercial su... See more »
March 17, 2019CoreRx Blog

CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, Increase Workforce

The post CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, I... See more »
November 2, 2018CoreRx Blog

CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)

Clearwater, Florida- November 4, 2018 - CoreRx, Inc. announces that its client Bionpharma has receive... See more »
November 2, 2018CoreRx Blog

CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI (Clobazam)

Clearwater, Florida- November 4, 2018 - CoreRx, Inc. announces that its client Bionpharma has receive... See more »
October 23, 2018CoreRx Blog

Installation of the Optel Line Master Serialization and Aggregation

Clearwater, Florida - As part of CoreRx, Inc's growth in expanding its cGMP manufacturing capabilitie... See more »

CoreRx Press Releases

CoreRx Videos

Social Media

Headquarters

14205 Myerlake Circle

Clearwater, Florida33760

727-259-6950

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

CoreRx is a contract development and manufacturing organization that provides formulation development, testing and pharmaceutical packaging services. CoreRx was founded in 2006. CoreRx's headquarters is located in Clearwater, Florida, USA 33760. It ha...

CEO

CoreRx's President & CEO, Todd R Daviau, currently has an approval rating of 85%. CoreRx's primary competitors are Formex, Tergus Pharma & KBI Biopharma.

Website

corerxpharma.com

Frequently Asked Questions about CoreRx

  1. When was CoreRx founded?

    CoreRx was founded in 2006
  2. Who is CoreRx's CEO?

    CoreRx's CEO is Todd R Daviau
  3. How much revenue does CoreRx generate?

    CoreRx generates $31.5M in revenue
  4. How much funding does CoreRx have?

    CoreRx has historically raised $15M in funding
  1. Where is CoreRx's headquarters?

    CoreRx's headquarters is in Clearwater Florida, USA
  2. How many employees does CoreRx have?

    CoreRx has 197 employees
  3. What sector does CoreRx operate in?

    CoreRx is in Biotechnology
  4. Who are CoreRx's competitors?

    CoreRx's top competitors are Formex, Tergus Pharma, KBI Biopharma